Revision history of "CREATION OF A BIOLOGICALLY ACTIVE COMPOSITE, KNOWN AS FIBROFILL COMPLEX, FOR THE REGENERATION OF THE MUCOSA" (Q2044181)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

11 October 2024

  • curprev 04:5404:54, 11 October 2024DG Regio talk contribs 49,801 bytes 0 Changed label, description and/or aliases in pt
  • curprev 04:5404:54, 11 October 2024DG Regio talk contribs 49,801 bytes +6 Set a claim value: summary (P836): O objectivo do projecto consiste em concluir os estudos sobre um INGREDIENTE BIOLÓGICO ACTIVO DE ORIGEM HUMANA a utilizar em associação com o ÁCIDO HIALURONICO, a explorar através das suas fontes regenerativas, FIBROFILL COMPLEX. Apoiando-se neste INGREDIENTE activo e começando pelo mecanismo de acção do medicamento FIBROLFILL, IG VALIDADO PELA AGÊNCIA EUROPEIA DE MEDICAMENTOS (EMA) E TOTALMENTE DESENVOLVIDO PELA ÚLTIMA INVESTIGAÇÃO, a LAZIOMAR pret...

7 March 2024

11 June 2023

26 April 2023

8 April 2023

5 July 2022

  • curprev 08:1708:17, 5 July 2022DG Regio talk contribs 46,675 bytes +30,409 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, pl, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, pl, sl, cs, lt, lv, bg, hu, ga, sv, et,

13 June 2022

9 February 2022

24 January 2022

24 December 2021

23 December 2021

16 December 2021

2 November 2020

17 July 2020

8 June 2020

24 March 2020

  • curprev 13:1813:18, 24 March 2020DG Regio talk contribs 9,285 bytes +887 Created claim: summary (P836): THE AIM OF THE PROJECT IS TO COMPLETE THE STUDIES ON A BIOLOGICAL ACTIVE INGREDIENT OF HUMAN ORIGIN TO BE USED IN COMBINATION WITH HYALURONIC ACID, TO BE EXPLOITED THROUGH ITS REGENERATIVE SOURCES, FIBROFILL COMPLEX. RELYING ON THIS ACTIVE INGREDIENT AND STARTING WITH THE ACTION MECHANISM OF THE MEDICINAL PRODUCT FIBROLFILL, GI VALIDATED BY THE EUROPEAN MEDICINES AGENCY (EMA) AND ENTIRELY DEVELOPED BY BELAST RESEARCH, LAZIOMAR INTENDS TO IMPLEM...
  • curprev 06:5806:58, 24 March 2020DG Regio talk contribs 8,398 bytes +433 Changed an Item

19 March 2020

12 March 2020

6 March 2020